Jong Gwang Kim

10PUBLICATIONS
20CO-AUTHORS
ChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 23, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

|Jul 22, 2023
Clinical implications and chemo-sensitivity of adjuvant chemotherapy in patients with poorly cohesive cells-gastric cancer.

Jin Ho Baek, Byung Woog Kang, Hyojeung Kang

|Mar 28, 2022
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.

Seung-Hoon Beom, Jong Gwang Kim, Seung Hyuk Baik

|Sep 10, 2021
Cisplatin Resistance in Epstein-Barr-Virus-Associated Gastric Carcinoma Acquired through ATM Methylation.

Sun Hee Lee, Su Jin Choi, Wonhyeok Choi

|Jan 30, 2021
Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.

In Hee Lee, Gyeonghwa Kim, Sang Gyu Kwak

|Nov 30, 2019
High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.

Dong Won Baek, Gyeonghwa Kim, Byung Woog Kang

Pageof 2

Frequent Collaborators

2 joint publications

Hyojeung Kang

1 joint publications

Eunhyun Ryu

1 joint publications

Dong Won Baek

1 joint publications

Keun Hur